ProCE Banner Events

Share

2023 Psychiatry Update NP/PA

Register now for our Psychiatry Update 2023: NP/PA series, which includes 5 dates in the spring and fall! This free program is offered in a virtual format with up to 5 CE credits and topics include schizophrenia, tardive dyskinesia, major depression, bipolar depression, and PTSD.

Join fellow healthcare professionals from around the nation for this popular series, now in its 3rd year! This series covers similar topics to our longstanding Psychiatry Update series with a very practical curriculum to manage these illnesses, with a target audience specifically of NPs and PAs. Register now to secure your seat!

Please note, attendees are asked to select one date, as you can only claim credit for this series once. If you have any questions or need to switch dates, please contact us at customersupport@cealliance.com

Registered Nurses: 5.00 Nursing contact hours, including 5.00 hours of pharmacotherapy credit

Physician Assistants/Physician Associates: 5.00 AAPA Category 1 CME credits

This event has expired. No longer available for credits.

Who Should Attend

This activity is intended for physician assistants/physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.

Time and location

Sunday, November 19, 2023

9:00 AM - 5:15 PM Eastern Time (ET)

Virtual

Faculty
Tamar Rodney, PhD, RN, PMHNP-BC, CNE

Assistant Professor
Nursing
Johns Hopkins University
Baltimore, Maryland

Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

Adjunct Faculty
Department of Health Sciences
West Liberty University
West Liberty, West Virginia

Tina Matthews-Hayes, DNP, FNP-BC, PMHNP-BC

Psychiatric Nurse Practitioner 
Seaside Behavioral Health 
Virginia Beach, Virginia 

Michael Asbach, DMSc, PA-C, Psych-CAQ

Associate Director International Psychiatry
DENT Neurologic Institute
Buffalo, New York

Amber Hoberg, PMHNP

Nurse Practitioner
MorningStar Family Medicine PLLC
Floresville, Texas

Michael Asbach, DMSc, PA-C, Psych-CAQ

Associate Director
Interventional Psychiatry
DENT Neurologic Institute
Amherst, New York

Kaylee Mehlman, PharmD, RPh, BCGP, FASCP

Clinical Consultant Pharmacist
Geramed Senior Care Consulting
Lakewood, OH

Agenda

*Tentative Agenda

9:00 AM – 9:05 AM: Opening Remarks by Moderator

9:05 AM – 10:05 AM: Avoiding Tardiness When Identifying and Treating Tardive Dyskinesia - Presented by: Amber Hoberg, MSN, APRN, PMHNP-BC

  • This session will provide a comprehensive overview of tardive dyskinesia, including risk factors, diagnosis, treatment options, and considerations for special populations. Patient case examples are included to simulate application of knowledge to practice.

10:05 AM – 10:15 AM: Break

10:15 AM – 11:15 AM: Clinical Perspectives on a Treatment Option for Bipolar Depression (Bipolar I and II) Non-CME Educational Talk Sponsored by Intra-Cellular Therapies, Inc. - Presented by: Michael T. Asbach, DMSc, PA-C, Psych-CAQ

  • Bipolar depression can be debilitating to patients, and difficulties in appropriate diagnosis and comorbidities can add to the challenge. This presentation will explore these challenges, as well as a treatment option approved for BOTH bipolar I and bipolar II depression in adults.

11:15 AM - 11:25 AM: Break

11:25 AM – 12:25 PM: Challenges in Schizophrenia Management - Presented by: Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

  • This session will cover schizophrenia from diagnosis to treatment options, including clinical pearls for ongoing management. Unmet needs and novel and emerging pharmacologic agents will also be discussed.

12:25 PM – 12:35 PM: Break

12:35 PM – 1:35 PM: Moving Forward: An Informed Approach to the Diagnosis and Treatment of Tardive Dyskinesia Non-CME Educational Talk Sponsored by Neurocrine Biosciences - Presented by: Kaylee Mehlman, PharmD, RPh, BCGP, FASCP

  • This program provides a straightforward overview of tardive dyskinesia, including its symptoms, prevalence, risk factors, and impact. Faculty will share the clinical data for an FDA-approved treatment option for adults with tardive dyskinesia. In addition, participants will have the opportunity to examine cases of real patients with tardive dyskinesia by observing videos of the patients before and after treatment. This program is non-CME educational content sponsored by Neurocrine Biosciences.

1:35 PM – 1:45 PM: Break

1:45 PM – 2:45 PM: A Better Understanding of Bipolar Depression - Presented by: Tina Matthews-Hayes, DNP, CRNP, FNP-BC, PMHNP-BC

  • This session will review the differential diagnosis of bipolar depression and differentiation of bipolar I and bipolar II to improve diagnostic accuracy. Treatment individualization will be discussed, including current and emerging treatment options for bipolar depression and how to individualize treatment selection for patients.

2:45 PM – 2:55 PM: Break

2:55 PM – 3:55 PM: Arguments for Augmentation: When to Augment vs Switch Medications in MDD - Presented by: Michael Asbach, DMSc, PA-C, Psych-CAQ

  • This session will provide an overview of differentiating switching and augmentation strategies for patients with lack of response in MDD. Evidence-based augmentation strategies, including antidepressants with different mechanisms of action, antipsychotics, and other agents recommended by guidelines, will be further discussed, and reinforced with a patient case demonstration.

3:55 PM – 4:05 PM: Break

4:05 PM – 5:05 PM: PTSD in the Community - Presented by: Tamar Rodney, PhD, RN, PMHNP-BC, CNE

  • This session will focus on manifestations of trauma in the community setting, diagnosis of PTSD, and current evidence-based treatment of PTSD with pharmacotherapy and psychotherapy tools. Emerging treatment options for PTSD will also be covered. 

5:05 PM – 5:15 PM: Closing Remarks by Moderator

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, competence, and performance of learners to assess diagnostic considerations and new and emerging therapies for the treatment of psychiatric illness.

Target Audience
This activity is intended for physician assistants/physician associates and nurse practitioners engaged in the care of patients with psychiatric illness.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Assess latest clinical evidence on new and emerging treatment options for patients with psychiatric disorders
  • Develop individualized treatment strategies for optimal outcomes in patients with psychiatric disorders
  • Discuss best practices in psychiatry to optimize patient care


Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Clinical Care Options, LLC (CCO), ProCE, LLC, and Practicing Clinicians Exchange. Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Nursing Continuing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 5.0 contact hours, including 5.0 hours of pharmacology credit

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC, in partnership with Practicing Clinicians Exchange.

Supported by educational grants from Intra-Cellular Therapies, Inc. and Neurocrine Biosciences, Inc.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:


Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.